CRScube hosts first breakout session on Japanese post-marketing surveillance (JPMS) enhancements

CRScube held its first breakout session dedicated to Japanese Post-Marketing Surveillance (JPMS) on 15th October 2024.

The session was attended by pharmaceutical companies and CROs who are users of cubeCDMS's JPMS functions. It included practical discussions about CRScube’s JPMS functions and a presentation by Seven to One, Inc. about solutions to problems in PMS tasks, advantages and improvements of JPMS functions, and an introduction and demo of automated workflows.

After such a successful event, we will develop this concept further to work closer with our clients in Japan.

Share via

See CRScube in action

Book a demo

Explore how our platform will elevate your team and clinical trial management.

Get insights straight to your inbox

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

A discussion with Stanley Kim and Rob Robertson

Although both CRScube and Mednet were built in different environments, there is a strong sense of culture and belonging at their core.

Beyond the data: Human stories from clinical trials in Ukraine

From halting patient recruitment and struggling with the shipment of investigational medicines, to relocating vulnerable oncology patients across borders, Anna paints a vivid picture of resilience and resourcefulness under pressure.

Why Mednet. Why Now.

CRScube and Mednet are a natural fit. We are both innovators in eClinical technology. We both operate on a SaaS model, serve the same customers, and believe in transforming clinical trials.